11.30
-0.19 (-1.65%)
| Previous Close | 11.49 |
| Open | 11.48 |
| Volume | 372,901 |
| Avg. Volume (3M) | 333,057 |
| Market Cap | 442,743,040 |
| Price / Earnings (Forward) | 20.04 |
| Price / Sales | 0.710 |
| Price / Book | 1.28 |
| 52 Weeks Range | |
| Earnings Date | 4 Aug 2025 - 8 Aug 2025 |
| Profit Margin | -17.78% |
| Operating Margin (TTM) | -17.64% |
| Diluted EPS (TTM) | -3.70 |
| Quarterly Revenue Growth (YOY) | 2.70% |
| Total Debt/Equity (MRQ) | 42.06% |
| Current Ratio (MRQ) | 2.71 |
| Operating Cash Flow (TTM) | 25.99 M |
| Levered Free Cash Flow (TTM) | 67.13 M |
| Return on Assets (TTM) | -5.00% |
| Return on Equity (TTM) | -27.82% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Bearish |
| Medical Devices (Global) | Bearish | Bearish | |
| Stock | Orthofix Medical Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | -1.5 |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 0.60 |
|
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 2.79% |
| % Held by Institutions | 87.90% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Ayal Capital Advisors Ltd | 31 Mar 2025 | 539,770 |
| 52 Weeks Range | ||
| Median | 16.00 (41.59%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barrington Research | 23 Jun 2025 | 16.00 (41.59%) | Buy | 10.80 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| FISHER PATRICK | - | 14.51 | -1,996 | -28,962 |
| Aggregate Net Quantity | -1,996 | |||
| Aggregate Net Value ($) | -28,962 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 14.51 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| FISHER PATRICK | Officer | 18 Aug 2025 | Sell (-) | 1,996 | 14.51 | 28,962 |
| Date | Type | Details |
|---|---|---|
| 05 Aug 2025 | Announcement | Orthofix Reports Second Quarter 2025 Financial Results |
| 16 Jul 2025 | Announcement | Orthofix to Participate at Canaccord Genuity 45th Annual Growth Conference |
| 15 Jul 2025 | Announcement | Orthofix to Report Second Quarter 2025 Financial Results |
| 17 Jun 2025 | Announcement | Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |